MedApp Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
MedApp's earnings have been declining at an average annual rate of -30.5%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 12.3% per year.
Anahtar bilgiler
-30.5%
Kazanç büyüme oranı
-29.7%
EPS büyüme oranı
| Healthcare Services Sektör Büyümesi | 16.1% |
| Gelir büyüme oranı | 12.3% |
| Özkaynak getirisi | -15.5% |
| Net Marj | -77.1% |
| Sonraki Kazanç Güncellemesi | 14 Nov 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Why Investors Shouldn't Be Surprised By MedApp S.A.'s (WSE:MDA) 26% Share Price Surge
Mar 26
Is It Too Late To Consider Buying MedApp S.A. (WSE:MDA)?
Jan 29Can You Imagine How Jubilant MedApp's (WSE:MDA) Shareholders Feel About Its 292% Share Price Gain?
Mar 12MedApp S.A.'s (WSE:MDA) Stock Is Going Strong: Have Financials A Role To Play?
Jan 18Announcing: MedApp (WSE:MDA) Stock Soared An Exciting 363% In The Last Five Years
Nov 26
Gelir ve Gider Dağılımı
MedApp nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 5 | -4 | 4 | 0 |
| 31 Mar 24 | 5 | -2 | 4 | 0 |
| 31 Dec 23 | 6 | -3 | 4 | 0 |
| 30 Sep 23 | 5 | -2 | 4 | 0 |
| 30 Jun 23 | 6 | 0 | 4 | 0 |
| 31 Mar 23 | 6 | 0 | 4 | 0 |
| 31 Dec 22 | 7 | 1 | 5 | 0 |
| 30 Sep 22 | 9 | 2 | 5 | 0 |
| 30 Jun 22 | 12 | 3 | 5 | 0 |
| 31 Mar 22 | 14 | 4 | 6 | 0 |
| 31 Dec 21 | 13 | 4 | 5 | 0 |
| 30 Sep 21 | 14 | 7 | 6 | 0 |
| 30 Jun 21 | 11 | 5 | 5 | 0 |
| 31 Mar 21 | 8 | 3 | 4 | 0 |
| 31 Dec 20 | 6 | 2 | 3 | 0 |
| 30 Sep 20 | 4 | 1 | 3 | 0 |
| 30 Jun 20 | 3 | 0 | 2 | 0 |
| 31 Mar 20 | 3 | 0 | 2 | 0 |
| 31 Dec 19 | 3 | 1 | 2 | 0 |
| 30 Sep 19 | 0 | 0 | -1 | 0 |
| 30 Jun 19 | 0 | 0 | 0 | 0 |
| 31 Mar 19 | 0 | -1 | 0 | 0 |
| 31 Dec 18 | 0 | -2 | 2 | 0 |
| 30 Sep 18 | 0 | -4 | 5 | 0 |
| 30 Jun 18 | 0 | -4 | 4 | 0 |
| 31 Mar 18 | 0 | -3 | 3 | 0 |
| 31 Dec 17 | 0 | -2 | 2 | 0 |
| 30 Sep 17 | 0 | -1 | 1 | 0 |
| 30 Jun 17 | 0 | -1 | 1 | 0 |
| 31 Mar 17 | 0 | -1 | 1 | 0 |
| 31 Dec 16 | 0 | -1 | 1 | 0 |
| 30 Sep 16 | 0 | -1 | 1 | 0 |
| 31 Mar 16 | 0 | -1 | 0 | 0 |
| 31 Dec 15 | 0 | -1 | 0 | 0 |
| 30 Sep 15 | 0 | -1 | 1 | 0 |
| 31 Mar 15 | 1 | 0 | 1 | 0 |
| 31 Dec 14 | 1 | -1 | 1 | 0 |
| 30 Sep 14 | 1 | -5 | 1 | 0 |
| 30 Jun 14 | 1 | -3 | 2 | 0 |
| 31 Mar 14 | 1 | -4 | 1 | 0 |
| 31 Dec 13 | 2 | -4 | 1 | 0 |
Kaliteli Kazançlar: MDA is currently unprofitable.
Büyüyen Kar Marjı: MDA is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: MDA is unprofitable, and losses have increased over the past 5 years at a rate of 30.5% per year.
Büyüme Hızlandırma: Unable to compare MDA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: MDA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (7.1%).
Özkaynak Getirisi
Yüksek ROE: MDA has a negative Return on Equity (-15.48%), as it is currently unprofitable.